Search Results

Pherecydes Pharma Granted United States Patent for Phage Therapy of Pseudomonas Infections.

• Source: Global IP News: Pharmaceutical Patent News. 2019.

Record details

Pherecydes Pharma Granted Patent for Phage Therapy of Pseudomonas Infections.

• Source: Global IP News: Pharmaceutical Patent News. 2018.

Record details

Characterization and genetic analysis of extensively drug-resistant hospital acquired Pseudomonas aeruginosa isolates.

• Authors : Abdelaziz MA; Department of Microbiology and Immunology, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt.; El-Aziz AMA

Subjects: Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/genetics ; Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/drug effects ; Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/isolation & purification

• Source: BMC microbiology [BMC Microbiol] 2024 Jun 26; Vol. 24 (1), pp. 225. Date of Electronic Publication: 2024 Jun 26.Publisher: BioMed Central Country of Publication: England NLM ID: 100966981 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2180

Record details

Epidemiology of healthcare-associated Pseudomonas aeruginosa in intensive care units: are sink drains to blame?

• Authors : Volling C; Department of Microbiology, Sinai Health, Toronto, Canada. Electronic address: .; Mataseje L

Subjects: Intensive Care Units*/Intensive Care Units*/Intensive Care Units*/statistics & numerical data ; Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/genetics ; Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/isolation & purification

• Source: The Journal of hospital infection [J Hosp Infect] 2024 Jun; Vol. 148, pp. 77-86. Date of Electronic Publication: 2024 Mar 28.Publisher: W.B. Saunders For The Hospital Infection Society Country of Publication: England NLM ID: 8007166 Publication Model: Print-Electronic Cited

Record details

Prevalence and molecular characterization of colistin resistance in Pseudomonas aeruginosa isolates: insights from a study in Ardabil hospitals.

• Authors : Jafari-Ramedani S; Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.; Nazari M

Subjects: Colistin*/Colistin*/Colistin*/pharmacology ; Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/genetics ; Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/drug effects

• Source: BMC microbiology [BMC Microbiol] 2024 May 03; Vol. 24 (1), pp. 152. Date of Electronic Publication: 2024 May 03.Publisher: BioMed Central Country of Publication: England NLM ID: 100966981 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2180

Record details

Dry powder inhalation containing muco-inert ciprofloxacin and colistin co-loaded liposomes for pulmonary P. Aeruginosa biofilm eradication.

• Authors : Wang J; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease Guangzhou Institute of Respiratory Health The First Affiliated Hospital of Guangzhou Medical University, 151 Yanjiang Road, Guangzhou 510120, Guangdong, China.; Guo Y

Subjects: Ciprofloxacin*/Ciprofloxacin*/Ciprofloxacin*/administration & dosage ; Ciprofloxacin*/Ciprofloxacin*/Ciprofloxacin*/pharmacology ; Ciprofloxacin*/Ciprofloxacin*/Ciprofloxacin*/chemistry

• Source: International journal of pharmaceutics [Int J Pharm] 2024 Jun 10; Vol. 658, pp. 124208. Date of Electronic Publication: 2024 May 07.Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium:

Record details

Microbiological and molecular studies on a multidrug-resistant Pseudomonas aeruginosa from a liver transplant patient with urinary tract infection in Egypt.

• Authors : Shaaban MT; Department of Botany and Microbiology, Faculty of Science, Menoufia University, Shebin El- Kom, Egypt.; Abdel-Raouf M

Subjects: Drug Resistance, Multiple, Bacterial*/Drug Resistance, Multiple, Bacterial*/Drug Resistance, Multiple, Bacterial*/genetics ; Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/genetics ; Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/Pseudomonas aeruginosa*/drug effects

• Source: BMC microbiology [BMC Microbiol] 2024 May 27; Vol. 24 (1), pp. 184. Date of Electronic Publication: 2024 May 27.Publisher: BioMed Central Country of Publication: England NLM ID: 100966981 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2180

Record details

Genome analyses of colistin-resistant high-risk bla NDM-5 producing Klebsiella pneumoniae ST147 and Pseudomonas aeruginosa ST235 and ST357 in clinical settings.

• Authors : Talat A; Medical Microbiology and Molecular Biology Lab, Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, 202002, India.; Khan F

Subjects: Klebsiella pneumoniae*/Klebsiella pneumoniae*/Klebsiella pneumoniae*/genetics ; Klebsiella pneumoniae*/Klebsiella pneumoniae*/Klebsiella pneumoniae*/drug effects ; Klebsiella pneumoniae*/Klebsiella pneumoniae*/Klebsiella pneumoniae*/isolation & purification

• Source: BMC microbiology [BMC Microbiol] 2024 May 20; Vol. 24 (1), pp. 174. Date of Electronic Publication: 2024 May 20.Publisher: BioMed Central Country of Publication: England NLM ID: 100966981 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2180

Record details

Multidrug resistance in Pseudomonas aeruginosa isolated from nosocomial respiratory and urinary infections in Aleppo, Syria.

• Authors : Mahfoud M; Faculty of Pharmacy, University of Aleppo, Aleppo, Syria. .; Al Najjar M

Subjects: Cross Infection/Cross Infection/Cross Infection/*microbiology ; Pseudomonas Infections/Pseudomonas Infections/Pseudomonas Infections/*microbiology ; Pseudomonas aeruginosa/Pseudomonas aeruginosa/Pseudomonas aeruginosa/*drug effects

• Source: Journal of infection in developing countries [J Infect Dev Ctries] 2015 Feb 19; Vol. 9 (2), pp. 210-3. Date of Electronic Publication: 2015 Feb 19.Publisher: Open Learning on Enteric Pathogens Country of Publication: Italy NLM ID: 101305410 Publication Model: Electronic Cited Medium: Internet

Record details

Pherecydes Pharma Submits United States Patent Application for Phage Therapy of Pseudomonas Infections.

• Source: Global IP News: Pharmaceutical Patent News. 2016.

Record details